These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. YAP activates the Hippo pathway in a negative feedback loop. Dai X; Liu H; Shen S; Guo X; Yan H; Ji X; Li L; Huang J; Feng XH; Zhao B Cell Res; 2015 Oct; 25(10):1175-8. PubMed ID: 26315483 [No Abstract] [Full Text] [Related]
7. MAP4K2 connects the Hippo pathway to autophagy in response to energy stress. Seo G; Mckinley J; Wang W Autophagy; 2024 Mar; 20(3):704-706. PubMed ID: 37937799 [TBL] [Abstract][Full Text] [Related]
8. Targeting the Hippo pathway: Clinical implications and therapeutics. Ye S; Eisinger-Mathason TS Pharmacol Res; 2016 Jan; 103():270-8. PubMed ID: 26678601 [TBL] [Abstract][Full Text] [Related]
9. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Mo JS; Meng Z; Kim YC; Park HW; Hansen CG; Kim S; Lim DS; Guan KL Nat Cell Biol; 2015 Apr; 17(4):500-10. PubMed ID: 25751140 [TBL] [Abstract][Full Text] [Related]
10. Hippo-YAP and mTOR pathways collaborate to regulate organ size. Csibi A; Blenis J Nat Cell Biol; 2012 Dec; 14(12):1244-5. PubMed ID: 23196842 [TBL] [Abstract][Full Text] [Related]
11. Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation. Lin Z; Pu WT Stem Cell Res; 2014 Nov; 13(3 Pt B):571-81. PubMed ID: 24881775 [TBL] [Abstract][Full Text] [Related]
12. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783 [TBL] [Abstract][Full Text] [Related]
13. Two faces of Hippo: activate or suppress the Hippo pathway in cancer. Cao J; Huang W Anticancer Drugs; 2017 Nov; 28(10):1079-1085. PubMed ID: 28926422 [TBL] [Abstract][Full Text] [Related]
14. Control of the hippo pathway by Set7-dependent methylation of Yap. Oudhoff MJ; Freeman SA; Couzens AL; Antignano F; Kuznetsova E; Min PH; Northrop JP; Lehnertz B; Barsyte-Lovejoy D; Vedadi M; Arrowsmith CH; Nishina H; Gold MR; Rossi FM; Gingras AC; Zaph C Dev Cell; 2013 Jul; 26(2):188-94. PubMed ID: 23850191 [TBL] [Abstract][Full Text] [Related]
15. Properly dividing with YAP. Pfeifer GP Sci Signal; 2016 Mar; 9(417):fs3. PubMed ID: 26933061 [TBL] [Abstract][Full Text] [Related]
16. Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway. Ehmer U; Sage J Mol Cancer Res; 2016 Feb; 14(2):127-40. PubMed ID: 26432795 [TBL] [Abstract][Full Text] [Related]
17. The Hippo pathway in tissue homeostasis and regeneration. Wang Y; Yu A; Yu FX Protein Cell; 2017 May; 8(5):349-359. PubMed ID: 28130761 [TBL] [Abstract][Full Text] [Related]
18. Hippo-YAP signaling pathway: A new paradigm for cancer therapy. Ma Y; Yang Y; Wang F; Wei Q; Qin H Int J Cancer; 2015 Nov; 137(10):2275-86. PubMed ID: 25042563 [TBL] [Abstract][Full Text] [Related]
19. The RAS and YAP1 dance, who is leading? Corbo V; Ponz-Sarvise M; Tuveson DA EMBO J; 2014 Nov; 33(21):2437-8. PubMed ID: 25257311 [TBL] [Abstract][Full Text] [Related]
20. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway. Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]